Therapeuticsmd, Inc. · NASDAQ:TXMD

Clearline Capital LP reported a 5.50% stake in Therapeuticsmd, Inc. (Schedule 13G)

Event Dec 31, 2024 · Filed Feb 12, 2025

Clearline Capital LP reported a 5.50% stake in Therapeuticsmd, Inc., 635,222 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G).

Stake
5.50%
Shares
635,222
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Clearline Capital LP5.50%635,222
Clearline Capital, LLC5.50%635,222
Marc Majzner5.50%635,222

Source

View original at SEC

Related